Yanmin Zhang

Title: Yanmin Zhang: Innovator in Mitochondrial Imaging and Therapeutics

Introduction

Yanmin Zhang is a prominent inventor based in Tempe, AZ (US). She has made significant contributions to the field of mitochondrial imaging and therapeutic targeting. With a total of 3 patents, her work focuses on innovative approaches to enhance the understanding and treatment of mitochondrial-related diseases.

Latest Patents

One of Yanmin Zhang's latest patents is titled "Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting." This invention relates to the use of prodrugs that are susceptible to nitroreductase (NTR) activation. The patent provides mitochondria-targeting prodrug compounds and probes, including profluorescent near-infrared (NIR) probes and non-fluorescent prodrugs. It also outlines methods for using these prodrug compounds and probes for imaging mitochondria and for mitochondria-specific delivery of therapeutic agents.

Career Highlights

Yanmin Zhang is affiliated with Arizona State University, where she continues to advance her research in the field of mitochondrial imaging. Her innovative work has garnered attention and recognition within the scientific community.

Collaborations

Yanmin has collaborated with notable colleagues, including Sidney M Hecht and Arnaud Chevalier. These collaborations have further enriched her research and contributed to the development of her patented technologies.

Conclusion

Yanmin Zhang's contributions to mitochondrial imaging and therapeutic targeting exemplify her dedication to innovation in science. Her patents reflect a commitment to advancing medical research and improving therapeutic strategies.